Safety and efficacy of mesenchymal stem cells in COVID-19 patients: A systematic review and meta-analysis.

Yan, Cai; Hu, Minjie; Dai, Rongjuan

Yan, Cai; Hu, Minjie; Dai, Rongjuan.

Affiliation

Yan C; Xiangtan Central Hospital, Department of Infectious diseases, Xiangtan, Hunan province, People's Republic of China.
Hu M; The First Affiliated Hospital, Department of Cardiothoracic Surgery, Hengyang Medical School, University of South China, Hengyang, Hunan province, People's Republic of China.
Dai R; The First Affiliated Hospital, Department of Infectious Diseases, Hengyang Medical School, University of South China, Hengyang, Hunan province, People's Republic of China.

Immun Inflamm Dis ; 11(9): e1000, 2023 09.

Article de En | MEDLINE | ID: mdl-37773722

Sujet(s)
Mots clés

COVID-19; clinical improvement; days to hospital discharge; mesenchymal stem cells; meta-analysis; mortality

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: COVID-19 Type d'étude: Clinical_trials / Systematic_reviews Limites: Humans Langue: En Journal: Immun Inflamm Dis Année: 2023 Type de document: Article Pays de publication: Royaume-Uni

Texte intégral

Ajouter à My VHL

Imprimer

XML

PubMed Links

Recherche sur Google